Why one person’s data is worth collecting
Adult clubfoot (talipes equinovarus outside the United States) is one of the least-studied ends of a well-studied condition. That leaves a choice: wait for evidence that has not arrived in forty years, or measure carefully and say exactly what the measurement is worth.
Turn these over
Six fair objections
Every one of these is a reasonable thing to think about a patient running studies on himself. Open each to see how far it goes.
“A study with one participant is not a study.” See what holds
It is not a trial and it cannot establish prevalence, effect size or generalisability. Anyone claiming otherwise from a single subject is overreaching, and these pages do not.
Single-subject designs are, though, a recognized method with a long history in rehabilitation and sports science. What they can do is track one system densely over time, which is exactly the shape of the adult clubfoot question.
“He is measuring himself, so he will find what he wants.” See what holds
Entirely fair. A motivated participant measuring himself, analyzing his own data and publishing his own conclusions has every opportunity to fool himself, and being aware of that is not the same as being immune to it.
What can be done about it is procedural: state the hypothesis before the data collection, publish the method, publish results that did not go the expected way, and keep the raw shape of the data visible and not only the conclusion.
“Without peer review it means nothing.” See what holds
Peer review is a filter, not a truth machine, and its absence here is stated plainly, not disguised with the furniture of a paper. Nothing on this site should be read as established fact because it appears in a study format.
What unreviewed, openly documented observation is legitimately good for is generating questions. “Here is a pattern I recorded over three years, does anyone else see this” is a useful sentence even when it is not a finding.
“Patients should leave research to researchers.” See what holds
If adult clubfoot were being actively studied, this would be a fair criticism and the sensible move would be to support that work instead. It is not. Follow-up largely stops at skeletal maturity, and the questions adults ask have no active program behind them.
Patient-led work in that vacuum is not competing with science. It is documenting something in the absence of anyone else doing so, and saying so honestly.
“This could lead people to make bad decisions.” See what holds
The genuine hazard here is not that the data is weak; it is that a study-shaped page carries authority it has not earned, and someone changes their treatment on the strength of one stranger’s numbers.
So every study page ends the same way: this is one person, do not act on it, take it to someone who can examine you. If a page ever reads as a recommendation, that is a fault worth reporting.
“Why so many studies instead of one good one?” See what holds
The program grew in phases. The first studies established what was actually happening; later ones asked what it meant; later still asked how the pattern was being maintained. Each raised the question the next one addresses.
That is honest about how the work developed, and it is also a limitation: a program that evolves as it goes is more prone to finding what it started looking for. The index shows the sequence so you can judge that for yourself.
What these studies can and cannot do
Legitimately
- Describe one system densely, over years
- Show that something is possible
- Generate hypotheses worth testing properly
- Document questions the literature has not asked
- Give adults language for what they are experiencing
Not at all
- Establish how common anything is
- Show a finding generalizes to you
- Compare treatments
- Support any clinical recommendation
- Substitute for being examined
One person, measured carefully, is a question. It is never an answer about anybody else.
How the program is organized
Eighteen studies in four phases, each phase asking the question the previous one raised. The naming is deliberately dull, 000A onward, because the sequence matters more than the titles.
The full index lists all eighteen with their status. The two most-read entry points are Study 000A on longitudinal adaptation and Study 000B on adaptive efficiency and internal cost.
People also ask
Patient-led research
What is patient-led research?
Is this peer reviewed?
Can I take part?
What can one person’s data actually show?
Why not just wait for proper studies?
Should I change anything based on these studies?
Related